changing your setting. We'll assume that you are happy to receive all cookies on the BTG website.
London, UK, 06 January 2011
BTG plc (LSE: BGC), the specialty pharmaceuticals company, today announces that its CEO, Dr Louise Makin, will be presenting at J.P. Morgan's 29th Annual Healthcare Conference in San Francisco on Thursday, 13 January 2011 at 9.30am PST (5.30pm GMT). The presentation slides will be available on BTG's website (www.btgplc.com) shortly after the presentation.
- ends -
For further information contact:
Andy Burrows, Director of Investor Relations
+44 (0)20 7575 1741
mobile: +44 (0)7990 530605
+44 (0)20 7831 3113
BTG is an international specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists, and is building a sustainable business financed by revenues from sales of its critical care products and from royalties and milestone payments on partnered products.
Select CONTINUE to proceed to the BTG website or LEAVE to learn more at BSC.com